Increasing Neonatal HIV Test and Treat to Maximize the Long-Term Impact on Infant Health and Novel Infant Antiretroviral Treatment
Recruiting
Observational Study
Vertical Human Immunodeficiency Virus Transmission
HIV Infection Pediatric
Infant Death
Infant Morbidity
Infant, Newborn, Diseases
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Observational
- Participants needed
- 6,000 (estimated)
- Sponsor
- Michael Hoelscher · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to improve HIV healthcare services for mothers living with HIV and their newborns in Tanzania and Mozambique. The main questions it aims to answer are: 1) does enhancing screening with maternal HIV viral load monitoring at delivery identify more mother-child pairs at high-risk for HIV vertical transmission? and 2) are high-risk infants linked to appropriate prevention and care? The…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Voluntary and informed consent of the mother for her own study participation (if applicable);
2. Voluntary and informed consent of the legal guardian of the child for participation of the child in the study;
3. Mothers/legal guardians ≥18 years of age;
4. Documented maternal …